A feed-forward loop amplifies nutritional regulation of PNPLA3

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,285 · see citing works

Steatohepatitis: A tale of two “hits”?

Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · see citing works

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092 · see citing works

Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity

Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664 · see citing works

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · see citing works

Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase

Zimmermann, R., Bogner‐Strauß, J. G., Haemmerle, G., Schoiswohl, G., Birner‐Gruenberger, R., Riederer, M., Lass, A., Neuberger, G., Eisenhaber, F., Hermetter, A., et al. (2004) · Science · doi:10.1126/science.1100747 · Cited by 2,121 · see citing works

Structure and function of the feed-forward loop network motif

Mangan, S., & Alon, U. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2133841100 · Cited by 1,827 · see citing works

Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβPreprint

Repa, J. J., Liang, G., Ou, J., Bashmakov, Y. K., Lobaccaro, J. A., Shimomura, I., Shan, B., Brown, M. S., Goldstein, J. L., & Mangelsdorf, D. J. (2000) · Genes & Development · doi:10.1101/gad.844900 · Cited by 1,693 · see citing works

Role of LXRs in control of lipogenesisPreprint

Schultz, J. R., Tu, H., Luk, A. Y., Repa, J. J., Medina, J. C., Li, L., Schwendner, S. W., Wang, S., Thoolen, M., Mangelsdorf, D. J., et al. (2000) · Genes & Development · doi:10.1101/gad.850400 · Cited by 1,673 · see citing works

Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells.

Shimano, H., Horton, J. D., Shimomura, I., Hammer, R. E., Brown, M. S., & Goldstein, J. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119248 · Cited by 842 · see citing works

Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.

Shimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., & Goldstein, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118951 · Cited by 816 · see citing works

Identification, Cloning, Expression, and Purification of Three Novel Human Calcium-independent Phospholipase A2 Family Members Possessing Triacylglycerol Lipase and Acylglycerol Transacylase Activities

Jenkins, C. M., Mancuso, D. J., Yan, W., Sims, H. F., Gibson, B., & Gross, R. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407841200 · Cited by 778 · see citing works

Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells.

Shimomura, I., Shimano, H., Horton, J. D., Goldstein, J. L., & Brown, M. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119247 · Cited by 760 · see citing works

Increased Levels of Nuclear SREBP-1c Associated with Fatty Livers in Two Mouse Models of Diabetes Mellitus

Shimomura, I., Bashmakov, Y. K., & Horton, J. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30028 · Cited by 708 · see citing works

Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2.

Horton, J. D., Shimomura, I., Brown, M. S., Hammer, R. E., Goldstein, J. L., & Shimano, H. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2961 · Cited by 703 · see citing works

Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice

Horton, J. D., Bashmakov, Y. K., Shimomura, I., & Shimano, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5987 · Cited by 669 · see citing works

Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c

Liang, G., Yang, J., Horton, J. D., Hammer, R. E., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111421200 · Cited by 669 · see citing works

Desnutrin, an Adipocyte Gene Encoding a Novel Patatin Domain-containing Protein, Is Induced by Fasting and Glucocorticoids

Villena, J. A., Roy, S., Sarkadi‐Nagy, E., Kim, K., & Sul, H. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403855200 · Cited by 606 · see citing works

A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis

He, S., McPhaul, C., Li, J. Z., Garuti, R., Kinch, L. N., Grishin, N. V., Cohen, J. C., & Hobbs, H. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064501 · Cited by 604 · see citing works

Non-alcoholic fatty liver disease: The mist gradually clears

de Alwis, N. M. W., & Day, C. P. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.009 · Cited by 603 · see citing works

Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver

Chen, G., Liang, G., Ou, J., Goldstein, J. L., & Brown, M. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404297101 · Cited by 546 · see citing works

Identification of Liver X Receptor-Retinoid X Receptor as an Activator of the Sterol Regulatory Element-Binding Protein 1c Gene Promoter

Yoshikawa, T., Shimano, H., Amemiya-Kudo, M., Yahagi, N., Hasty, A. H., Matsuzaka, T., Okazaki, H., Tamura, Y., Iizuka, Y., Ohashi, K., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.2991-3000.2001 · Cited by 526 · see citing works

Sterol Resistance in CHO Cells Traced to Point Mutation in SREBP Cleavage–Activating Protein

Hua, X., Nohturfft, A., Goldstein, J. L., & Brown, M. S. (1996) · Cell · doi:10.1016/s0092-8674(00)81362-8 · Cited by 478 · see citing works

Population-Based Genome-wide Association Studies Reveal Six Loci Influencing Plasma Levels of Liver Enzymes

Yuan, X., Waterworth, D. M., Perry, J. R. B., Lim, N., Song, K. S., Chambers, J. C., Zhang, W., Vollenweider, P., Stirnadel-Farrant, H. A., Johnson, T., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.09.012 · Cited by 449 · see citing works

Variant in PNPLA3 is associated with alcoholic liver disease

Tian, C., Stokowski, R. P., Kershenobich, D., Ballinger, D. G., & Hinds, D. A. (2009) · Nature Genetics · doi:10.1038/ng.488 · Cited by 435 · see citing works

Adipose Triglyceride Lipase: Function, Regulation by Insulin, and Comparison With Adiponutrin

Kershaw, E. E. (2006) · Diabetes · doi:10.2337/diabetes.55.1.148 · Cited by 386 · see citing works

Nuclear Sterol Regulatory Element-binding Proteins Activate Genes Responsible for the Entire Program of Unsaturated Fatty Acid Biosynthesis in Transgenic Mouse Liver

Shimomura, I., Shimano, H., Korn, B. S., Bashmakov, Y. K., & Horton, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35299 · Cited by 383 · see citing works

A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity

Sookoian, S. C., Castaño, G. O., Burgueño, A. L., Gianotti, T. F., Rosselli, M. S., & Pirola, C. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p900013-jlr200 · Cited by 367 · see citing works

SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevationPreprint

Matsuda, M., Korn, B. S., Hammer, R. E., Moon, Y.-A., Komuro, R., Horton, J. D., Goldstein, J. L., Brown, M. S., & Shimomura, I. (2001) · Genes & Development · doi:10.1101/gad.891301 · Cited by 338 · see citing works

Mammalian patatin domain containing proteins: a family with diverse lipolytic activities involved in multiple biological functions

Kienesberger, P. C., Oberer, M., Lass, A., & Zechner, R. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800082-jlr200 · Cited by 331 · see citing works

Characterization of the human patatin-like phospholipase family

Wilson, P. A., Gardner, S. D., Lambie, N. M., Commans, S., & Crowther, D. J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600185-jlr200 · Cited by 297 · see citing works

Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members

Lake, A. C., Sun, Y., Li, J., Kim, J. E., Johnson, J., Li, D., Revett, T., Shih, H. H., Liu, W., Paulsen, J. E., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500290-jlr200 · Cited by 294 · see citing works

A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans

Kotronen, A., Johansson, L. E., Johansson, L., Roos, C., Westerbacka, J., Hamsten, A., Bergholm, R., Arkkila, P., Arola, J. T., Kiviluoto, T. A., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1285-z · Cited by 288 · see citing works

The Crystal Structure, Mutagenesis, and Activity Studies Reveal that Patatin Is a Lipid Acyl Hydrolase with a Ser-Asp Catalytic Dyad

Rydel, T. J., Williams, J. M., Krieger, E. K., Moshiri, F., Stallings, W. C., Brown, S. M., Pershing, J. C., Purcell, J. P., & Alibhai, M. F. (2003) · Biochemistry · doi:10.1021/bi027156r · Cited by 284 · see citing works

Adiponutrin, a Transmembrane Protein Corresponding to a Novel Dietary- and Obesity-linked mRNA Specifically Expressed in the Adipose Lineage

Baulande, S., Lasnier, F., Lucas, M., & Pairault, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105193200 · Cited by 252 · see citing works

Ethnic Differences in the Prevalence of Cryptogenic Cirrhosis

Browning, J. D., Kumar, K. S., Saboorian, M. H., & Thiele, D. L. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04059.x · Cited by 227 · see citing works

42 bp element from LDL receptor gene confers end-product repression by sterols when inserted into viral TK promoter

Südhof, T. C., Russell, D. W., Brown, M. S., & Goldstein, J. L. (1987) · Cell · doi:10.1016/0092-8674(87)90713-6 · Cited by 213 · see citing works

ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver

Denechaud, P., Bossard, P., Lobaccaro, J. A., Millatt, L. J., Staels, B., Girard, J. R., & Postic, C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34314 · Cited by 205 · see citing works

A MAJOR SOLUBLE GLYCOPROTEIN OF POTATO TUBERS

Racusen, D., & Foote, M. W. (1980) · Journal of Food Biochemistry · doi:10.1111/j.1745-4514.1980.tb00876.x · Cited by 190 · see citing works

The enzymic deacylation of phospholipids and galactolipids in plants. Purification and properties of a lipolytic acyl-hydrolase from potato tubers

GALLIARD, T. (1971) · Biochemical Journal · doi:10.1042/bj1210379 · Cited by 171 · see citing works

Proteasome inhibition and aggregation in Parkinson's disease: a comparative study in untransfected and transfected cells

Biasini, E., Fioriti, L., Ceglia, I., Invernizzi, R. W., Bertoli, A., Chiesa, R., & Forloni, G. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02152.x · Cited by 167 · see citing works

The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status

Hoekstra, M., Li, Z., Kruijt, J. K., Eck, M. V., Berkel, T. J. C. V., & Kuiper, J. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.004 · Cited by 108 · see citing works

Unsaturated Fatty Acids Inhibit Proteasomal Degradation of Insig-1 at a Postubiquitination Step

Lee, J. N., Zhang, X., Feramisco, J. D., Gong, Y., & Ye, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806108200 · Cited by 104 · see citing works

Genome-wide analysis of SREBP-1 binding in mouse liver chromatin reveals a preference for promoter proximal binding to a new motif

Seo, Y., Chong, H. K., Infante, A. M., Im, S., Xie, X. S., & Osborne, T. F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904246106 · Cited by 104 · see citing works

Triacsins, new inhibitors of acyl-CoA synthetase produced by Streptomyces sp.

Ōmura, S., Tomoda, H., XU, Q. M., Takahashi, Y., & IWAI, Y. (1986) · The Journal of Antibiotics · doi:10.7164/antibiotics.39.1211 · Cited by 85 · see citing works

Regulation of hormone-sensitive lipase during fasting

Sztalryd, C., & Kraemer, F. B. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.2.e179 · Cited by 80 · see citing works

Discovering Novel Sequence Motifs with MEME

Bailey, T. L. (2002) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0204s00 · Cited by 74 · see citing works

A common variant in the adiponutrin gene influences liver enzyme values

Kollerits, B., Coassin, S., Zollner-Kiechl, S., Hunt, S. C., Paulweber, B., Willeit, J., Kloss‐Brandstätter, A., Lamina, C., Adams, T. D., & Kronenberg, F. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.066597 · Cited by 70 · see citing works

Mechanisms for Insulin Resistance: Common Threads and Missing Links

Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294 · see citing works

Human Fatty Liver Disease: Old Questions and New Insights

Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089 · see citing works

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

Yki‐Järvinen, H. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70032-4 · Cited by 1,260 · see citing works

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

Sookoian, S. C., & Pirola, C. J. (2011) · Hepatology · doi:10.1002/hep.24283 · Cited by 917 · see citing works

Peroxisome Proliferator-Activated Receptor Alpha Target Genes

Rakhshandehroo, M., Knoch, B., Müller, M., & Kersten, S. (2010) · PPAR Research · doi:10.1155/2010/612089 · Cited by 1,020 · see citing works

Lipolysis – A highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores

Lass, A., Zimmermann, R., Oberer, M., & Zechner, R. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.10.004 · Cited by 641 · see citing works

Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum

Hardy, T., Oakley, F., Anstee, Q. M., & Day, C. P. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044224 · Cited by 619 · see citing works

Recent progress in phospholipase A2 research: From cells to animals to humans

Murakami, M., Taketomi, Y., Miki, Y., Sato, H., Hirabayashi, T., & Yamamoto, K. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.12.001 · Cited by 509 · see citing works

Insulin Resistance, Obesity and Lipotoxicity

Yazıcı, D., & Sezer, H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_12 · Cited by 507 · see citing works

Mechanisms of liver fibrosis and its role in liver cancer

Dhar, D., Baglieri, J., Kisseleva, T., & Brenner, D. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219898141 · Cited by 440 · see citing works

Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation

Kim, C.-W., Addy, C., Kusunoki, J., Anderson, N. N., Deja, S., Fu, X., Burgess, S. C., Li, C., Ruddy, M., Chakravarthy, M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.009 · Cited by 419 · see citing works

Update on NAFLD genetics: From new variants to the clinic

Trépo, E., & Valenti, L. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.020 · Cited by 393 · see citing works

Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci

Stender, S., Kozlitina, J., Nordestgaard, B. G., Tybjærg‐Hansen, A., Hobbs, H. H., & Cohen, J. C. (2017) · Nature Genetics · doi:10.1038/ng.3855 · Cited by 401 · see citing works

Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis

Smagris, E., BasuRay, S., Li, J., Huang, Y., Lai, K. V., Gromada, J., Cohen, J. C., & Hobbs, H. H. (2015) · Hepatology · doi:10.1002/hep.27242 · Cited by 379 · see citing works

PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells

Pirazzi, C., Valenti, L. V. C., Motta, B. M., Pingitore, P., Hedfalk, K., Mancina, R. M., Burza, M. A., Indiveri, C., Ferro, Y., Montalcini, T., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu121 · Cited by 363 · see citing works

The genetics of NAFLD

Anstee, Q. M., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.182 · Cited by 332 · see citing works

Mammalian Triacylglycerol Metabolism: Synthesis, Lipolysis, and Signaling

Coleman, R., & Mashek, D. G. (2011) · Chemical Reviews · doi:10.1021/cr100404w · Cited by 332 · see citing works

Targeting Fat: Mechanisms of Protein Localization to Lipid Droplets

Kory, N., Farese, R. V., & Walther, T. C. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.02.007 · Cited by 317 · see citing works

DAG tales: the multiple faces of diacylglycerol—stereochemistry, metabolism, and signaling

Eichmann, T. O., & Lass, A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1982-3 · Cited by 315 · see citing works

Adiponutrin Functions as a Nutritionally Regulated Lysophosphatidic Acid Acyltransferase

Kumari, M., Schoiswohl, G., Chitraju, C., Paar, M., Cornaciu, I., Rangrez, A. Y., Wongsiriroj, N., Nagy, H. M., Ivanova, P. T., Scott, S. A., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.008 · Cited by 313 · see citing works

Expression and Characterization of a PNPLA3 Protein Isoform (I148M) Associated with Nonalcoholic Fatty Liver Disease

Huang, Y., Cohen, J. C., & Hobbs, H. H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.290114 · Cited by 312 · see citing works

Low Doses of Bisphenol A Induce Gene Expression Related to Lipid Synthesis and Trigger Triglyceride Accumulation in Adult Mouse Liver

Marmugi, A., Ducheix, S., Lasserre, F., Polizzi, A., Paris, A., Priymenko, N., Bertrand‐Michel, J., Pineau, T., Guillou, H., Martin, P. G. P., et al. (2011) · Hepatology · doi:10.1002/hep.24685 · Cited by 306 · see citing works

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors

Juanola, O., Martínez‐López, S., Francés, R., & Gómez‐Hurtado, I. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18105227 · Cited by 303 · see citing works

The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation

BasuRay, S., Smagris, E., Cohen, J. C., & Hobbs, H. H. (2017) · Hepatology · doi:10.1002/hep.29273 · Cited by 302 · see citing works

Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro

Pirazzi, C., Adiels, M., Burza, M. A., Mancina, R. M., Levin, M. C., Ståhlman, M., Taskinen, M., Orho‐Melander, M., Perman, J., Pujia, A., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.030 · Cited by 300 · see citing works

PNPLA3 gene in liver diseases

Trépo, E., Romeo, S., Zucman‐Rossi, J., & Nahon, P. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.03.011 · Cited by 293 · see citing works

I148M Patatin-Like Phospholipase Domain-Containing 3 Gene Variant and Severity of Pediatric Nonalcoholic Fatty Liver Disease

Valenti, L. V. C., Alisi, A., Galmozzi, E., Bartuli, A., Menico, B. D., Alterio, A., Dongiovanni, P., Fargion, S. R., & Nobili, V. (2010) · Hepatology · doi:10.1002/hep.23823 · Cited by 288 · see citing works

Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis

BasuRay, S., Wang, Y., Šmagris, Ē., Cohen, J. C., & Hobbs, H. H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901974116 · Cited by 285 · see citing works

Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis

Li, J. Z., Huang, Y., Karaman, R., Ivanova, P. T., Brown, H. A., Roddy, T. P., Castro‐Perez, J. M., Cohen, J. C., & Hobbs, H. H. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65179 · Cited by 280 · see citing works

The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells

Bruschi, F. V., Claudel, T., Tardelli, M., Caligiuri, A., Stulnig, T. M., Marra, F., & Trauner, M. (2017) · Hepatology · doi:10.1002/hep.29041 · Cited by 268 · see citing works

Variant in the glucokinase regulatory protein ( GCKR ) gene is associated with fatty liver in obese children and adolescents

Santoro, N., Zhang, C. K., Zhao, H., PAKSTIS, A. J., Kim, G., Kursawe, R., Dykas, D. J., Bale, A. E., Giannini, C., Pierpont, B. M., et al. (2011) · Hepatology · doi:10.1002/hep.24806 · Cited by 263 · see citing works

Advances in Pediatric Nonalcoholic Fatty Liver Disease†

Loomba, R. S., Sirlin, C. B., Schwimmer, J. B., & Lavine, J. E. (2009) · Hepatology · doi:10.1002/hep.23119 · Cited by 262 · see citing works

PNPLA3 I148M polymorphism and progressive liver disease

Dongiovanni, P. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i41.6969 · Cited by 252 · see citing works

Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics

Yang, A., & Mottillo, E. P. (2020) · Biochemical Journal · doi:10.1042/bcj20190468 · Cited by 250 · see citing works

Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping

Liu, Z., Zhang, Y., Graham, S. E., Wang, X., Cai, D., Huang, M., Piqué-Regi, R., Dong, X. C., Chen, Y. E., Willer, C. J., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.006 · Cited by 250 · see citing works

Patatin-Like Phospholipase Domain-Containing 3/Adiponutrin Deficiency in Mice Is Not Associated with Fatty Liver Disease†,‡

Chen, W., Chang, B. H., Li, L., & Chan, L. (2010) · Hepatology · doi:10.1002/hep.23812 · Cited by 246 · see citing works

Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome

Basantani, M. K., Sitnick, M. T., Cai, L., Brenner, D., Gardner, N. P., Li, J. Z., Schoiswohl, G., Yang, K., Kumari, M., Gross, R. W., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m011205 · Cited by 239 · see citing works

Non-alcoholic fatty liver disease and risk of cardiovascular disease

Lonardo, A., Sookoian, S. C., Pirola, C. J., & Targher, G. (2015) · Metabolism · doi:10.1016/j.metabol.2015.09.017 · Cited by 236 · see citing works

Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment

Dongiovanni, P., Anstee, Q. M., & Valenti, L. V. C. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990381 · Cited by 231 · see citing works

Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins

Smagris, E., Gilyard, S., BasuRay, S., Cohen, J. C., & Hobbs, H. H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.719955 · Cited by 226 · see citing works

Metabolic drivers of non-alcoholic fatty liver disease

Bence, K. K., & Birnbaum, M. J. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101143 · Cited by 223 · see citing works

Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption

Davis, J. N., Lê, K., Walker, R. W., Vikman, S., Spruijt‐Metz, D., Weigensberg, M. J., Allayee, H., & Goran, M. I. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.30185 · Cited by 204 · see citing works

Updating Phospholipase A2 Biology

Murakami, M., Sato, H., & Taketomi, Y. (2020) · Biomolecules · doi:10.3390/biom10101457 · Cited by 197 · see citing works

Lipid droplets: size matters

Suzuki, M., Shinohara, Y., Ohsaki, Y., & Fujimoto, T. (2011) · Microscopy · doi:10.1093/jmicro/dfr016 · Cited by 196 · see citing works

Liver X Receptors in Atherosclerosis and Inflammation

Im, S., & Osborne, T. F. (2011) · Circulation Research · doi:10.1161/circresaha.110.226878 · Cited by 192 · see citing works

Toward a unifying hypothesis of metabolic syndrome

Bremer, A. A., Mietus-Snyder, M., & Lustig, R. H. (2012) · PEDIATRICS · doi:10.1542/peds.2011-2912 · Cited by 186 · see citing works

Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic

Hassan, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.12082 · Cited by 186 · see citing works

Therapeutic Landscape for NAFLD in 2020

Neuschwander‐Tetri, B. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.051 · Cited by 183 · see citing works

Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C

Trépo, E., Pradat, P., Potthoff, A., Momozawa, Y., Quertinmont, E., Gustot, T., Lemmers, A., Berthillon, P., Amininejad, L., Chevallier, M., et al. (2011) · Hepatology · doi:10.1002/hep.24350 · Cited by 176 · see citing works

Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis

Carlsson, B., Lindén, D., Brolén, G., Liljeblad, M., Bjursell, M., Romeo, S., & Loomba, R. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15738 · Cited by 169 · see citing works

The Metabolically Benign and Malignant Fatty Liver

Stefan, N., & Häring, H. (2011) · Diabetes · doi:10.2337/db11-0231 · Cited by 172 · see citing works

A 360-degree overview of paediatric NAFLD: Recent insights

Nobili, V., Svegliati‐Baroni, G., Alisi, A., Miele, L., Valenti, L. V. C., & Vajro, P. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.003 · Cited by 168 · see citing works

The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2

Day, C. P., & Anstee, Q. M. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562947 · Cited by 161 · see citing works

Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids

Luukkonen, P. K., Nick, A., Hölttä‐Vuori, M., Thiele, C., Isokuortti, E., Lallukka-Brück, S. E., Zhou, Y., Hakkarainen, A., Lundbom, N. M. I., Peltonen, M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.127902 · Cited by 161 · see citing works

Genetic and epigenetic factors determining NAFLD risk

Jonas, W., & Schürmann, A. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101111 · Cited by 157 · see citing works

Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis

Dongiovanni, P., Romeo, S., & Valenti, L. V. C. (2015) · BioMed Research International · doi:10.1155/2015/460190 · Cited by 150 · see citing works

Genetic determinants of alcoholic liver disease

Stickel, F., & Hampe, J. (2011) · Gut · doi:10.1136/gutjnl-2011-301239 · Cited by 150 · see citing works

Hepatic lipid droplet biology: Getting to the root of fatty liver

Mashek, D. G., Khan, S. A., Sathyanarayan, A., Ploeger, J. M., & Franklin, M. P. (2015) · Hepatology · doi:10.1002/hep.27839 · Cited by 149 · see citing works

Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease

Trépo, E., Gustot, T., Degré, D., Lemmers, A., Verset, L., Demetter, P., Ouziel, R., Quertinmont, E., Vercruysse, V., Amininejad, L., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.028 · Cited by 148 · see citing works

Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors

Dongiovanni, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12945 · Cited by 145 · see citing works

Genomics in Personalized Nutrition: Can You “Eat for Your Genes”?

Mullins, V. A., Bresette, W., Johnstone, L. M., Hallmark, B., & Chilton, F. H. (2020) · Nutrients · doi:10.3390/nu12103118 · Cited by 151 · see citing works

Genetic determinants of hepatic steatosis in man

Hooper, A. J., Adams, L. A., & Burnett, J. R. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r008896 · Cited by 142 · see citing works

Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes

Dubuquoy, C., Robichon, C., Lasnier, F., Langlois, C., Dugail, I., Foufelle, F., Girard, J. R., Burnol, A., Postic, C., & Moldes, M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.024 · Cited by 139 · see citing works

Expression of SREBP-1c Requires SREBP-2-mediated Generation of a Sterol Ligand for LXR in Livers of Mice

Rong, S., Cortés, V. A., Rashid, S., Anderson, N. N., McDonald, J. G., Liang, G., Moon, Y.-A., Hammer, R. E., & Horton, J. D. (2017) · eLife · doi:10.7554/elife.25015 · Cited by 134 · see citing works

NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment

Xia, M., Bian, H., & Gao, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00877 · Cited by 133 · see citing works

The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus

Zeng, X., Varady, K. A., Wang, X., Targher, G., Byrne, C. D., Tayyem, R., Latella, G., Bergheim, I., Valenzuela, R., George, J., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156028 · Cited by 131 · see citing works

Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology

Sookoian, S. C., Pirola, C. J., Valenti, L. V. C., & Davidson, N. O. (2020) · Hepatology · doi:10.1002/hep.31229 · Cited by 129 · see citing works

Hepatic transcriptional responses to fasting and feeding

Bideyan, L., Nagari, R., & Tontonoz, P. (2021) · Genes & Development · doi:10.1101/gad.348340.121 · Cited by 126 · see citing works

Nutrition and Genetics in NAFLD: The Perfect Binomium

Meroni, M., Longo, M., Rustichelli, A., & Dongiovanni, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082986 · Cited by 122 · see citing works

Effects of PNPLA3 on Liver Fat and Metabolic Profile in Hispanic Children and Adolescents

Goran, M. I., Walker, R. W., Lê, K., Mahurkar‐Joshi, S., Vikman, S., Davis, J. N., Spruijt‐Metz, D., Weigensberg, M. J., & Allayee, H. (2010) · Diabetes · doi:10.2337/db10-0554 · Cited by 121 · see citing works

Dynamic interactions of ABHD5 with PNPLA3 regulate triacylglycerol metabolism in brown adipocytes

Yang, A., Mottillo, E. P., Mladenovic-Lucas, L., Li, Z., & Granneman, J. G. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0066-3 · Cited by 119 · see citing works

PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence

Falleti, E., Fabris, C., Cmet, S., Cussigh, A., Bitetto, D., Fontanini, E., Fornasiere, E., Bignulin, S., Fumolo, E., Bignulin, E., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02534.x · Cited by 118 · see citing works

PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals

Burza, M. A., Pirazzi, C., Maglio, C., Sjöholm, K., Mancina, R. M., Svensson, P., Jacobson, P., Adiels, M., Baroni, M. G., Borén, J., et al. (2012) · Digestive and Liver Disease · doi:10.1016/j.dld.2012.05.006 · Cited by 118 · see citing works

SIRT1 Mediates the Effect of GLP-1 Receptor Agonist Exenatide on Ameliorating Hepatic Steatosis

Xu, F., Li, Z., Zheng, X., Liu, H., Liang, H., Xu, H., Chen, Z., Zeng, K., & Weng, J. (2014) · Diabetes · doi:10.2337/db14-0263 · Cited by 114 · see citing works

Genetics of nonalcoholic fatty liver disease

Dongiovanni, P., & Valenti, L. V. C. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.018 · Cited by 115 · see citing works

Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese

Tang, C. S.-M., Zhang, H., Cheung, C. Y. Y., Xu, M., Ho, J. C.-Y., Zhou, W., Cherny, S. S., Zhang, Y., Holmen, O. L., Au, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms10206 · Cited by 110 · see citing works

PNPLA3 mediates hepatocyte triacylglycerol remodeling

Ruhanen, H., Perttilä, J., Hölttä‐Vuori, M., Zhou, Y., Yki‐Järvinen, H., Ikonen, E., Käkelä, R., & Olkkonen, V. M. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m046607 · Cited by 114 · see citing works

The role of PNPLA3 in health and disease

Pingitore, P., & Romeo, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.06.018 · Cited by 115 · see citing works

Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond

Krawczyk, M. J., Liebe, R., & Lammert, F. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.053 · Cited by 110 · see citing works

Metabolic dysfunction–associated fatty liver disease and the risk of 24 specific cancers

Liu, Z., Lin, C., Suo, C., Zhao, R., Li, J., Zhang, T., & Chen, X. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154955 · Cited by 110 · see citing works

Hepatic Fat Accumulation Is Modulated by the Interaction between the rs738409 Variant in the PNPLA3 Gene and the Dietary Omega6/Omega3 PUFA Intake

Santoro, N., Savoye, M., Kim, G., Marotto, K., Shaw, M. M., Pierpont, B., & Caprio, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037827 · Cited by 108 · see citing works

Patatin-like phospholipase domain–containing protein 3 promotes transfers of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets

Mitsche, M. A., Hobbs, H. H., & Cohen, J. C. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002333 · Cited by 109 · see citing works

Hepatic steatosis in Wilson disease – Role of copper and PNPLA3 mutations

Stättermayer, A. F., Traussnigg, S., Dienes, H., Aigner, E. S., Stauber, R. E., Lackner, K., Hofer, H., Stift, J., Wrba, F., Stadlmayr, A., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.034 · Cited by 107 · see citing works

Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker

Baselli, G., Dongiovanni, P., Rametta, R., Meroni, M., Pelusi, S., Maggioni, M., Badiali, S., Pingitore, P., Maurotti, S., Montalcini, T., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319226 · Cited by 106 · see citing works

The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications

Palma, R., Pronio, A., Romeo, M., Scognamiglio, F., Ventriglia, L., Ormando, V. M., Lamazza, A., Pontone, S., Federico, A., & Dallio, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133649 · Cited by 111 · see citing works

PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein

Johnson, S. M., Bao, H., McMahon, C. E., Chen, Y., Burr, S. D., Anderson, A. M., Madeyski-Bengtson, K., Lindén, D., Han, X., & Liu, J. (2024) · Nature Communications · doi:10.1038/s41467-024-49224-x · Cited by 100 · see citing works

DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER

Rong, S., Xia, M., Vale, G., Wang, S., Kim, C.-W., Li, S., McDonald, J. G., Radhakrishnan, A., & Horton, J. D. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.01.011 · Cited by 102 · see citing works

TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis

Hsieh, J., Koseki, M., Molusky, M. M., Yakushiji, E., Ichi, I., Westerterp, M., Iqbal, J., Chan, R., Abramowicz, S., Tascau, L., et al. (2016) · Nature · doi:10.1038/nature18628 · Cited by 99 · see citing works

PNPLA3/adiponutrin functions in lipid droplet formation

Chamoun, Z., Vacca, F., Parton, R. G., & Gruenberg, J. E. (2013) · Biology of the Cell · doi:10.1111/boc.201200036 · Cited by 99 · see citing works

The PNPLA3 I148M variant increases ketogenesis and decreases hepatic de novo lipogenesis and mitochondrial function in humans

Luukkonen, P. K., Porthan, K., Ahlholm, N., Rosqvist, F., Dufour, S., Zhang, X., Lehtimäki, T. E., Seppänen, W., Orho‐Melander, M., Hodson, L., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.008 · Cited by 97 · see citing works

Paradoxical Lower Serum Triglyceride Levels and Higher Type 2 Diabetes Mellitus Susceptibility in Obese Individuals with the PNPLA3 148M Variant

Palmer, C. N. A., Maglio, C., Pirazzi, C., Burza, M. A., Adiels, M., Burch, L. R., Donnelly, L. A., Colhoun, H. M., Doney, A. S. F., Dillon, J. F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039362 · Cited by 94 · see citing works

PNPLA3-Associated Steatohepatitis: Toward a Gene-Based Classification of Fatty Liver Disease

Krawczyk, M. J., Portincasa, P., & Lammert, F. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1358525 · Cited by 92 · see citing works

Eicosanoids in Metabolic Syndrome

Hardwick, J. P., Eckman, K., Lee, Y., Abdelmegeed, M. A., Esterle, A. R., Chilian, W. M., Chiang, J. Y. L., & Song, B. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-404717-4.00005-6 · Cited by 91 · see citing works

Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: Non-invasive elastography-based study in chronic liver disease

Krawczyk, M. J., Grünhage, F., Zimmer, V., & Lammert, F. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.042 · Cited by 89 · see citing works

Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats

Kumashiro, N., Yoshimura, T., Cantley, J. L., Majumdar, S. K., Guebre‐Egziabher, F., Kursawe, R., Vatner, D. F., Fat, I., Kahn, M., Erion, D. M., et al. (2012) · Hepatology · doi:10.1002/hep.26170 · Cited by 88 · see citing works

PNPLA3 is regulated by glucose in human hepatocytes, and its I148M mutant slows down triglyceride hydrolysis

Perttilä, J., Samanez, C. H., Caron, S., Tanhuanpää, K., Staels, B., Yki‐Järvinen, H., & Olkkonen, V. M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00125.2011 · Cited by 87 · see citing works

PNPLA3—A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease

Dong, X. C. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00304 · Cited by 86 · see citing works

Mouse patatin-like phospholipase domain-containing 3 influences systemic lipid and glucose homeostasis

Qiao, A., Liang, J., Ke, Y., Li, C., Cui, Y., Shen, L., Zhang, H., Cui, A., Liu, X., Liu, C., et al. (2011) · Hepatology · doi:10.1002/hep.24402 · Cited by 85 · see citing works

Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice

Fuchs, C. D., Claudel, T., Kumari, P., Haemmerle, G., Pollheimer, M. J., Stojaković, T., Scharnagl, H., Halilbasic, E., Gumhold, J., Silbert, D., et al. (2012) · Hepatology · doi:10.1002/hep.25601 · Cited by 84 · see citing works

A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease

Dongiovanni, P., & Valenti, L. V. C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071534 · Cited by 84 · see citing works

PNPLA3 Gene Expression is Regulated by Carbohydrates and Unsaturated Fatty Acids in vitro and in vivo

Hao, L., Ito, K., Wray, A. E., Mueller, N. M., Atluri, M., & Ross, C. (2012) · The FASEB Journal · doi:10.1096/fasebj.26.1_supplement.242.8

SIRT1 mediates nutritional regulation of SREBP-1c-driven hepatic PNPLA3 transcription via modulation of H3k9 acetylation

Xu, X. L., Deng, X., Chen, Y., Xu, W., Xu, F. L., & Liang, H. (2022) · Genes and Environment · doi:10.1186/s41021-022-00246-1 · Cited by 8 · see citing works

Mouse patatin-like phospholipase domain-containing 3 influences systemic lipid and glucose homeostasis

Qiao, A., Liang, J., Ke, Y., Li, C., Cui, Y., Shen, L., Zhang, H., Cui, A., Liu, X., Liu, C., et al. (2011) · Hepatology · doi:10.1002/hep.24402 · Cited by 85 · see citing works

PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease

Sookoian, S. C. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i42.6018 · Cited by 64 · see citing works

Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis

Smagris, E., BasuRay, S., Li, J., Huang, Y., Lai, K. V., Gromada, J., Cohen, J. C., & Hobbs, H. H. (2015) · Hepatology · doi:10.1002/hep.27242 · Cited by 379 · see citing works